Delivery Order SPE2DB24D2100-SPE2DB25FBEUN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on July 21, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa (abiraterone acetate) is a specialized pharmaceutical used in the treatment of prostate cancer, reflecting...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a 120-count quantity. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp is a major...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of YONSA (abiraterone acetate) 125 mg tablets in a quantity of 120 units, valued at $2,271.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a $2.27K delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for supply of YONSA (abiraterone acetate) 125 mg tablets in a 120-count package. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Yonsa 125 mg tablets (120-count units) valued at $2,271.36 with a firm fixed price structure. The order is scheduled for completion by May 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a delivery order under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Yonsa 125 mg tablets (120-count units) with a contract ceiling value of $4,542.74 and a firm fixed price structure. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by July 2, 2025. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Yonsa 125 mg tablets (120-count package) valued at $2,271.36 with a firm fixed price structure. This delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a $4,542.74 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of 120 tablets of Yonsa 125 mg, with performance completion targeted for August 22, 2025. This firm fixed-price contract was awarded without set-aside designation through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa is a prescription medication used in oncology treatment, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) under a firm fixed-price contract valued at $2,271.36, with an ultimate completion date of July 17, 2025. This competitive award, issued on June 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Yonsa 125 mg tablets (120 count). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBEUNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a quantity of 120 units, with a ceiling value of $4,542.74 and completion date of July 11, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. Yonsa is a specialty pharmaceutical used in the treatment of prostate cancer and reflects AmerisourceBergen's role as a critical vendor for federal medical procurement across therapeutic domains. As a major pharmaceutical distributor serving military and veteran healthcare systems, AmerisourceBergen maintains an extensive portfolio of federal contract awards with DLA and the Defense Health Agency. The company's DLA Troop Support Medical IDC enables flexible delivery of pharmaceuticals, vaccines, medical devices, and supplies to support military healthcare programs globally, positioning the company as a key participant in the Department of Defense's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 6/18/25 |